Net Cash Provided by (Used in) Operating Activities |
-342M |
USD |
+73.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-583M |
USD |
-141% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
771M |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
86.9M |
shares |
+0.12% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-155M |
USD |
-2370% |
Q1 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
188M |
USD |
-0.92% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
168M |
USD |
-11.3% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
119M |
USD |
-2.62% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
22.4M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
50.3M |
USD |
|
Q3 2022 |
Q3 2022 |
Preferred Stock, Shares Outstanding |
22.4M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
168M |
USD |
-11.3% |
Q4 2023 |
FY 2023 |
Interest Expense |
713M |
USD |
+12.2% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |